Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

Studies show psilocybin from mushrooms could revolutionize depression treatment offering hope to millions who don't respond to traditional medications.

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

Participants in clinic trial went from being unable to get out of bed to being productive and interacting with loved ones ...

Scientists have discovered how brain circuits affected by stress can predict resilience in mice. By stimulating certain neurons, they could transform less resilient mice into ones that actively sought ...

Neumora Therapeutics' (NMRA.O), opens new tab shares tumbled more than 80% on Thursday after its experimental depression drug failed to reduce symptoms such as sadness and pessimistic thoughts in a ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...

In a groundbreaking Interview, Professor Raz Yirmiya discusses his innovative research at the intersection of inflammation ...

Hebrew University's Professor Raz Yirmiya shares pioneering discoveries about inflammation's role in depression. His research ...

Experts say chronic depression affects a lot of adults here in Oklahoma, and they say that the weather, seasonal depression, ...

New research on the most effective treatments ... Experts believe that such biomarkers can be used to guide treatment. Depression and anxiety after stroke often co-occur alongside cognitive ...